This excerpt taken from the SYT 6-K filed Jul 28, 2005.
septoria resistance and in eastern Europe where sales again showed double digit growth in these rapidly expanding markets. Elsewhere, sales were affected by unfavorable weather conditions, with a cold start to the season followed by drought in southern Europe, notably Spain.
This excerpt taken from the SYT 6-K filed Feb 15, 2005.
septoria resistance in European cereals, contributed to a double-digit increase in fungicide sales, with AMISTAR® exceeding $500 million. Insecticides benefited from the roll-out of new combination products while solid growth in herbicides demonstrated the strength of this product line. Professional Products continued a record of top line growth driven largely by the expansion of seed treatment. Total sales of new products grew by 32 percent (CER) to reach $688 million with continuing growth in the CALLISTO® range ($289 million) and in ACTARA®/CRUISER® ($298 million) as well as the successful launch of ENVOKE® on cotton in the USA. The range rationalization program reduced sales by $49 million (CER) in 2004. This four year program, with a cumulative sales impact of $301 million, is now complete. EBITDA rose by 22 percent (CER) to $1463 million.
This excerpt taken from the SYT 6-K filed Jan 18, 2005.
Syngenta is a world-leading agribusiness committed to sustainable agriculture through innovative research and technology. The company is a leader in crop protection, and ranks third in the high-value commercial seeds market. Sales in 2003 were approximately $6.6 billion. Syngenta employs some 19,000 people in over 90 countries. Syngenta is listed on the Swiss stock exchange (SYNN) and in New York (SYT). Further information is available at www.syngenta.com.
Syngenta 17 January 2005 / Page 1 of 1
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.